C.K. Cheng
Co-founder and General Partner @ Acorn Pacific Ventures
San Francisco Bay Area, United States
C.K. Cheng is a Series D investor at Acorn Pacific Ventures in San Francisco Bay Area focused on Medical and Life Science. Chih-Kai Cheng is the Co-founder and General Partner at Acorn Pacific Ventures. Chih-Kai Cheng attended National Chiao Tung University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries C.K. Cheng invests in
Stages C.K. Cheng invests in
Countries C.K. Cheng invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Life Science 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancerantigens.Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California. | $60M / Series D / Jan 22, 2018 |
Co-Investors
About Acorn Pacific Ventures
Acorn Pacific Ventures helps entrepreneurs execute technology strategies.
Acorn Pacific Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
C.K. Cheng
Co-founder and General Partner
|
|||
C.K. Cheng
Co-founder and General Partner
|
|||
|
Derek Chau
Partner
|
|||
Peter Hsieh
General Partner
|
|||
Howard Chau
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does C.K. Cheng invest in?
C.K. Cheng invests primarily in Medical, Life Science and Therapeutics startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact C.K. Cheng?
Public channels for C.K. Cheng include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did C.K. Cheng last invest?
The most recent investment recorded for C.K. Cheng closed in Jan 2018. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
